HOME >> MEDICINE >> NEWS
Media undermine efforts to tackle nicotine addiction

Inaccurate media reports surrounding the safety of new smoking cessation drugs are undermining the treatment of nicotine addiction, according to an editorial in this week's BMJ.

Professor Linda Ferry presents two scenarios that illustrate the struggle between the press and medical experts to investigate and report concerns about the safety of new drugs for smoking cessation, and the effect this struggle has on reported attempts to quit smoking.

In the United Kingdom, bupropion hydrochloride (Zyban) was heralded by the media as a wonder drug when it was released in 2000. Not surprisingly, smokers queued up in waiting rooms, expecting their tobacco addiction to be vanish with this new pill.

The public enthusiasm changed abruptly in February 2001 when a London newspaper profiled a few dramatic reports of deaths in smokers using bupropion. Although experts remain convinced of the safety of bupropion, the demand for treatment has declined.

A similar shift in public opinion followed media reports in the United States about an increased risk of heart attack associated with nicotine patches. A subsequent trial showed that patches were safe to use, specifically in patients with heart disease, but many smokers still believe the original media messages that if I use a patch and smoke even one cigarette, I might have a heart attack.

Clinicians should give clear messages to their patients that it is much safer to use either of these drugs to help their attempts to quit than to continue smoking, says the author. Unfortunately, much damage has been done.

Tobacco treatment specialists and public health agencies need to refute the inaccuracies of the media and present a clear picture of the enormous problem of preventable disability and the 120,000 tobacco related deaths a year from the 13 million smokers in the United Kingdom, she concludes.


'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
6-Jun-2002


Page: 1

Related medicine news :

1. Media update: GSA underscores hottest meeting topics
2. Media invitation first annual EDCTP Forum
3. Media invitation - European Society of Cardiology Congress 2004
4. Media invitation: The Movement Disorder Societys 7th International Congress
5. Media Advisory-- Results of California autism epidemiology study to be unveiled
6. Review of preliminary observations concludes the Mayo Clinic Natl Conf on Medicine and the Media
7. Media focus on endostatin helped -- not hurt --
8. Media advisory: Mayo Clinic study finds infliximab safe and beneficial for Crohns disease
9. Media coverage of new drugs is often misleading
10. Media advisory: Mayo Clinic study shows increased incidence of migraines in women
11. American Heart Association Media Advisory: Cholesterol Lowering Margarines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... February 20, 2017 , ... Researchers at the University of ... well as a marker that may predict response to a particular class of drugs, ... of cancer as well. The new findings were published in Proceedings of the National ...
(Date:2/20/2017)... ... February 20, 2017 , ... Today, ... Biscom Document Router (BDR), the first IoT device from Biscom designed to deliver ... Biscom will debut BDR at HIMSS17 and will be conducting demonstrations ...
(Date:2/20/2017)... Sunapee, NH (PRWEB) , ... February 20, 2017 , ... ReportingMD, a Population Health Software ... rapid growth of the company. The new location will triple the size of the ... location for the town of Sunapee, NH. , “We are excited to expand ...
(Date:2/20/2017)... ... 2017 , ... Chuck E. Cheese’s® and Center for Autism and Related Disorders ... E. Cheese’s locations throughout New England, New York and New Jersey to provide children ... fun of visiting Chuck E. Cheese’s in a sensory-friendly environment. , After a ...
(Date:2/19/2017)... ... , ... The Citadel’s new Swain Department of Nursing , along with ... Ph.D. Joseph was engaged by the college as a consultant to help build the ... a nation-wide search, she was selected to head the department as nurse administrator, assuming ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... India , February 20, 2017 According to ... (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), ... 2021" published by MarketsandMarkets, The market is projected to reach USD 52.37 ... of 6.5% during the forecast period. Continue ... ...
(Date:2/20/2017)... 2017   Alberty   Drugs , ... has announced a significant shift in focus ... programs to servicing local Veteran Affairs Centers (VA) and ... an increased need to secure cost effective treatments for ... locally for their goods & services. "The ...
(Date:2/20/2017)... Acute, Chronic and Prophylaxis GVHD The global graft versus ... from 2016-2021 and CAGR of 3% from 2021-2027. The market is expected ... market is estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn ... How this report ... the future business opportunities emerging in this sector. In this ...
Breaking Medicine Technology:
Cached News: